David Novack - Aug 23, 2021 Form 4 Insider Report for DYNAVAX TECHNOLOGIES CORP (DVAX)

Role: President & COO
Signature: David Novack, by /s/ Justin Burgess, Attorney-in-Fact
Stock symbol: DVAX
Transactions as of: Aug 23, 2021
Transactions value $: -$112,770
Form type: 4
Date filed: 8/25/2021, 07:35 PM
Previous filing: Aug 13, 2021
Next filing: Sep 3, 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DVAX	Common Stock	Award	$8.48K	+2.5K	+2.33%	$3.39	110K	Aug 13, 2021	Direct	F1
transaction	DVAX	Common Stock	Options Exercise	$18.8K	+4.17K	+3.79%	$4.50	114K	Aug 23, 2021	Direct
transaction	DVAX	Common Stock	Sale	-$140K	-10K	-8.77%	$14.00	104K	Aug 24, 2021	Direct	F2, F3

Showing 1 to 3 of 3 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DVAX	Warrant (Right to Buy)	Options Exercise		-4.17K	-100%		0	Aug 23, 2021	Common Stock	4.17K	$4.50	Direct	F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents 2,500 shares acquired under Issuer's 2014 Employee Stock Purchase Plan (ESPP) on August 13, 2021
F2	The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 1, 2021.
F3	All shares were sold at $14.00
F4	Warrants were issued in connection with a financing transaction dated August 12, 2019 and were immediately exercisable upon issuance and have an expiration date of February 12, 2022.
F5	Not applicable